In accordance with these data, the use of GHRH analog to increase endogenous GH in adults with obesity and GH deficiency has been proposed, and it has shown a positive effect in reducing visceral fat, body fat mass and systemic inflammation [37,38]. This evidence concerns the gene GH1 and obesity disorder.